Wdr45 Protein (Wipr1) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
**Protein Name:** WDR45 (WIPR1)
**Gene:** WDR45
**UniProt ID:** Q9Y5X9
**Molecular Weight:** 39 kDa
**Subcellular Localization:** Cytoplasm, Autophagosomes
**Protein Family:** WD40 repeat family
**Aliases:** WIPR1, WDR45L
WDR45 (also called WIPR1) is a WD40 repeat protein involved in autophagy and iron metabolism. It plays a critical role in autophagosome formation and cellular iron homeostasis. Mutations cause neurodegeneration with brain iron accumulation (NBIA).
WDR45 contains:
- WD40 Repeats: Six WD40 repeat domains forming a beta-propeller structure
- Autophagy-binding motifs: Regions interacting with autophagy proteins
- Iron-sulfur cluster binding: Potential 2Fe-2S cluster coordination
WDR45 is essential for autophagy:
- Autophagosome Biogenesis: Required for proper formation of autophagosomes
- Iron Metabolism: Regulates cellular iron homeostasis
- Lysosomal Function: Coordinates with the autophagy-lysosomal pathway
- Protein Quality Control: Facilitates clearance of damaged organelles
- Neuroprotection: Protects against oxidative stress
WDR45 mutations cause X-linked NBIA:
- Progressive iron accumulation in globus pallidus and substantia nigra
- Progressive dystonia and parkinsonism
- Cognitive decline
- Typically affects males; heterozygous females may show milder symptoms
Static Encephalopathy of Childhood with Neurodegeneration in Adulthood:
- Initial static encephalopathy in childhood
- Neurodegenerative course in adulthood
- Progressive movement disorders
| Strategy |
Approach |
Status |
| Iron Chelation |
Deferoxamine, deferasirox |
Standard of care |
| Autophagy Modulation |
mTOR inhibitors, rapamycin |
Research |
| Gene Therapy |
AAV-delivered WDR45 |
Preclinical |
-
Haack TB, et al. (2012). "Exome sequencing identifies WDR45 mutations." Am J Hum Genet 91(1):149-159. PMID:22677156.[1]
-
Saitsu H, et al. (2013). "WDR45 mutations in NBIA and SENDA." Nat Genet 45(7):770-775. PMID:23542699.[2]
-
Liu Y, et al. (2020). "WDR45 and autophagy in neurodegeneration." J Mol Neurosci 70(4):507-515. PMID:32062731.[3]
WDR45-related NBIA presents unique clinical challenges:
- Serum ferritin elevated in NBIA subtypes
- Brain MRI shows characteristic iron deposition in globus pallidus
- T2 hypointensity on susceptibility-weighted imaging (SWI)
- Motor symptoms typically appear in childhood or adolescence
- Progressive dystonia often leads to disability
- Cognitive decline correlates with iron accumulation in basal ganglia
- Life expectancy varies; some patients survive into adulthood
- Iron chelation therapy is standard of care
- Physical therapy for dystonia management
- Deep brain stimulation considered in select cases
- Multidisciplinary care involving neurology, genetics, and rehabilitation
- Understanding WDR45's role in autophagosome formation
- Developing gene therapy approaches for WDR45 deficiency
- Identifying biomarkers for disease progression
- Exploring autophagy-enhancing compounds
- WDR45 knockout mouse models show iron accumulation
- Zebrafish models demonstrate developmental defects
- Patient-derived iPSCs used for disease modeling
- In vitro systems for drug screening
WDR45 interacts with several key proteins:
| Partner |
Interaction Type |
Function |
| WDR45B |
Homolog |
Redundant autophagy function |
| LC3 (MAP1LC3A) |
Binding |
Autophagosome recruitment |
| ATG14 |
Binding |
Autophagy initiation complex |
| p62/SQSTM1 |
Binding |
Selective autophagy receptor |
| NCOA4 |
Binding |
Ferritinophagy mediator |
- Phosphorylation: Regulates autophagy activity
- Sumoylation: Affects protein stability
- Ubiquitination: Targets for degradation
WDR45 is conserved across eukaryotes:
- Drosophila ortholog (wdr45) essential for viability
- Yeast homologs involved in autophagy
- WD40 repeat architecture preserved across species
The study of Wdr45 Protein (Wipr1) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Haack TB, et al. (2012). Exome sequencing identifies WDR45 mutations. Am J Hum Genet 91(1):149-159. PMID:22677156.
- Saitsu H, et al. (2013). WDR45 mutations in NBIA and SENDA. Nat Genet 45(7):770-775. PMID:23542699.
- Liu Y, et al. (2020). WDR45 and autophagy in neurodegeneration. J Mol Neurosci 70(4):507-515. PMID:32062731.